Free Trial

Optimistic reception of the news that a.......>

FOREX
FOREX: Optimistic reception of the news that a Covid-19 vaccine developed by
Moderna produced antibodies in all participants of the trial flicked the risk
switch to on, but a closer look into reports on the matter revealed some
caveats. Second thoughts, combined with with boiling U.S.-China tensions,
limited market reaction. Commodity-tied FX lead gains in G10 FX space, with safe
havens still underperforming, albeit crosses are back from earlier extremes.
- Renewed risk appetite pushed AUD/JPY to its best levels in a month. The rate
moved in sync with AUD/USD, which had a look above $0.7000 and a key resistance
from Jul 9 high of $0.7001, before trimming gains.
- KRW picked up a bid at the re-open of onshore trade, drawing support from
aforementioned risk-on flows & a surprise downtick in South Korea's unemployment
rate. The won gradually shed some of the initial gains.
- USD/CNH slid below the CNH7.0 mark, but failed to consolidate there. Partial
unwinding of earlier risk-on flows prompted the rate to recoup some losses.
- Coming up today we have UK CPI, U.S. industrial output, as well as a MonPol
decision from the BoC. Speaker slate features BoE's Tenreyro & Fed's Harker.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.